vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and Fortinet (FTNT). Click either name above to swap in a different company.

Fortinet is the larger business by last-quarter revenue ($1.9B vs $994.2M, roughly 1.9× Charles River Laboratories). Fortinet runs the higher net margin — 26.6% vs -27.8%, a 54.4% gap on every dollar of revenue. On growth, Fortinet posted the faster year-over-year revenue change (14.8% vs -0.8%). Fortinet produced more free cash flow last quarter ($577.4M vs $58.6M). Over the past eight quarters, Fortinet's revenue compounded faster (18.6% CAGR vs -0.9%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

Fortinet, Inc. is an American cybersecurity company headquartered in Sunnyvale, California. It develops and sells security products including firewalls, endpoint security and intrusion detection systems. Fortinet has offices in the US, Canada, and UK.

CRL vs FTNT — Head-to-Head

Bigger by revenue
FTNT
FTNT
1.9× larger
FTNT
$1.9B
$994.2M
CRL
Growing faster (revenue YoY)
FTNT
FTNT
+15.6% gap
FTNT
14.8%
-0.8%
CRL
Higher net margin
FTNT
FTNT
54.4% more per $
FTNT
26.6%
-27.8%
CRL
More free cash flow
FTNT
FTNT
$518.8M more FCF
FTNT
$577.4M
$58.6M
CRL
Faster 2-yr revenue CAGR
FTNT
FTNT
Annualised
FTNT
18.6%
-0.9%
CRL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRL
CRL
FTNT
FTNT
Revenue
$994.2M
$1.9B
Net Profit
$-276.6M
$506.0M
Gross Margin
79.6%
Operating Margin
-28.5%
32.8%
Net Margin
-27.8%
26.6%
Revenue YoY
-0.8%
14.8%
Net Profit YoY
-28.9%
-3.8%
EPS (diluted)
$-5.57
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
FTNT
FTNT
Q4 25
$994.2M
$1.9B
Q3 25
$1.0B
$1.7B
Q2 25
$1.0B
$1.6B
Q1 25
$984.2M
$1.5B
Q4 24
$1.0B
$1.7B
Q3 24
$1.0B
$1.5B
Q2 24
$1.0B
$1.4B
Q1 24
$1.0B
$1.4B
Net Profit
CRL
CRL
FTNT
FTNT
Q4 25
$-276.6M
$506.0M
Q3 25
$54.4M
$473.9M
Q2 25
$52.3M
$440.1M
Q1 25
$25.5M
$433.4M
Q4 24
$-214.5M
$526.2M
Q3 24
$69.7M
$539.9M
Q2 24
$94.1M
$379.8M
Q1 24
$73.0M
$299.3M
Gross Margin
CRL
CRL
FTNT
FTNT
Q4 25
79.6%
Q3 25
80.8%
Q2 25
80.7%
Q1 25
81.0%
Q4 24
81.1%
Q3 24
34.6%
82.5%
Q2 24
34.5%
80.8%
Q1 24
34.1%
77.5%
Operating Margin
CRL
CRL
FTNT
FTNT
Q4 25
-28.5%
32.8%
Q3 25
13.3%
31.7%
Q2 25
9.7%
28.1%
Q1 25
7.6%
29.5%
Q4 24
-16.7%
34.6%
Q3 24
11.6%
31.2%
Q2 24
14.8%
30.5%
Q1 24
12.5%
23.7%
Net Margin
CRL
CRL
FTNT
FTNT
Q4 25
-27.8%
26.6%
Q3 25
5.4%
27.5%
Q2 25
5.1%
27.0%
Q1 25
2.6%
28.1%
Q4 24
-21.4%
31.7%
Q3 24
6.9%
35.8%
Q2 24
9.2%
26.5%
Q1 24
7.2%
22.1%
EPS (diluted)
CRL
CRL
FTNT
FTNT
Q4 25
$-5.57
$0.67
Q3 25
$1.10
$0.62
Q2 25
$1.06
$0.57
Q1 25
$0.50
$0.56
Q4 24
$-4.17
$0.68
Q3 24
$1.33
$0.70
Q2 24
$1.74
$0.49
Q1 24
$1.30
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
FTNT
FTNT
Cash + ST InvestmentsLiquidity on hand
$213.8M
$2.5B
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$3.2B
$1.2B
Total Assets
$7.1B
$10.4B
Debt / EquityLower = less leverage
0.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
FTNT
FTNT
Q4 25
$213.8M
$2.5B
Q3 25
$207.1M
$2.0B
Q2 25
$182.8M
$3.4B
Q1 25
$229.4M
$3.6B
Q4 24
$194.6M
$2.9B
Q3 24
$210.2M
$2.5B
Q2 24
$179.2M
$2.2B
Q1 24
$327.0M
$1.9B
Total Debt
CRL
CRL
FTNT
FTNT
Q4 25
$2.1B
Q3 25
$2.2B
Q2 25
$2.3B
Q1 25
$2.5B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.4B
Q1 24
$2.7B
Stockholders' Equity
CRL
CRL
FTNT
FTNT
Q4 25
$3.2B
$1.2B
Q3 25
$3.4B
$735.1M
Q2 25
$3.4B
$2.1B
Q1 25
$3.2B
$2.0B
Q4 24
$3.5B
$1.5B
Q3 24
$3.8B
$908.1M
Q2 24
$3.7B
$288.2M
Q1 24
$3.6B
$-137.5M
Total Assets
CRL
CRL
FTNT
FTNT
Q4 25
$7.1B
$10.4B
Q3 25
$7.5B
$9.4B
Q2 25
$7.6B
$10.6B
Q1 25
$7.6B
$10.4B
Q4 24
$7.5B
$9.8B
Q3 24
$8.0B
$8.9B
Q2 24
$7.9B
$8.1B
Q1 24
$8.2B
$7.7B
Debt / Equity
CRL
CRL
FTNT
FTNT
Q4 25
0.68×
Q3 25
0.64×
Q2 25
0.70×
Q1 25
0.79×
Q4 24
0.65×
Q3 24
0.62×
Q2 24
0.65×
Q1 24
0.73×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
FTNT
FTNT
Operating Cash FlowLast quarter
$147.5M
$620.2M
Free Cash FlowOCF − Capex
$58.6M
$577.4M
FCF MarginFCF / Revenue
5.9%
30.3%
Capex IntensityCapex / Revenue
8.9%
2.2%
Cash ConversionOCF / Net Profit
1.23×
TTM Free Cash FlowTrailing 4 quarters
$518.5M
$2.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
FTNT
FTNT
Q4 25
$147.5M
$620.2M
Q3 25
$213.8M
$655.2M
Q2 25
$204.6M
$451.9M
Q1 25
$171.7M
$863.3M
Q4 24
$159.4M
$477.6M
Q3 24
$251.8M
$608.1M
Q2 24
$193.5M
$342.0M
Q1 24
$129.9M
$830.4M
Free Cash Flow
CRL
CRL
FTNT
FTNT
Q4 25
$58.6M
$577.4M
Q3 25
$178.2M
$567.5M
Q2 25
$169.3M
$284.1M
Q1 25
$112.4M
$796.8M
Q4 24
$83.7M
$380.0M
Q3 24
$213.1M
$571.8M
Q2 24
$154.0M
$318.9M
Q1 24
$50.7M
$608.5M
FCF Margin
CRL
CRL
FTNT
FTNT
Q4 25
5.9%
30.3%
Q3 25
17.7%
32.9%
Q2 25
16.4%
17.4%
Q1 25
11.4%
51.8%
Q4 24
8.4%
22.9%
Q3 24
21.1%
37.9%
Q2 24
15.0%
22.2%
Q1 24
5.0%
45.0%
Capex Intensity
CRL
CRL
FTNT
FTNT
Q4 25
8.9%
2.2%
Q3 25
3.5%
5.1%
Q2 25
3.4%
10.3%
Q1 25
6.0%
4.3%
Q4 24
7.5%
5.9%
Q3 24
3.8%
2.4%
Q2 24
3.8%
1.6%
Q1 24
7.8%
16.4%
Cash Conversion
CRL
CRL
FTNT
FTNT
Q4 25
1.23×
Q3 25
3.93×
1.38×
Q2 25
3.91×
1.03×
Q1 25
6.74×
1.99×
Q4 24
0.91×
Q3 24
3.61×
1.13×
Q2 24
2.06×
0.90×
Q1 24
1.78×
2.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Discovery And Safety Assessment Segment$591.6M60%
Manufacturing Support Segment$196.4M20%
Transferred At Point In Time$108.0M11%
Transferred Over Time$98.3M10%

FTNT
FTNT

Services$1.2B64%
Security Subscription$693.7M36%

Related Comparisons